AMED: Amedisys, Inc.
About
Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.
Current Value
$89.761 Year Return
Current Value
$89.761 Year Return
Key Details
Market Cap
$2.95B
P/E Ratio
35.84
1Y Stock Return
-3.95%
1Y Revenue Growth
4.19%
Dividend Yield
0.00%
Price to Book
2.6
Strategies that include AMED
Stock's related to AMED
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SPNS | 36.63% | $1.52B | +6.33% | 2.13% |
| MDB | 32.94% | $21.36B | -28.69% | 0.00% |
| ARC | 29.23% | $146.66M | +18.95% | 5.90% |
| PHAT | 26.36% | $640.70M | +29.96% | 0.00% |
| MRVL | 25.02% | $77.39B | +63.39% | 0.27% |
| VEEV | 23.69% | $33.99B | +18.99% | 0.00% |
| APT | 22.70% | $58.84M | +13.35% | 0.00% |
| PBI | 22.48% | $1.41B | +100.00% | 2.57% |
| PTCT | 22.45% | $3.04B | +80.14% | 0.00% |
| NDLS | 22.29% | $31.59M | -76.95% | 0.00% |
| SNOW | 21.53% | $43.66B | -21.86% | 0.00% |
| KD | 21.43% | $6.51B | +55.09% | 0.00% |
| S | 21.33% | $8.76B | +59.38% | 0.00% |
| FUN | 21.03% | $4.60B | -16.51% | 0.00% |
| UCTT | 20.29% | $1.60B | +35.62% | 0.00% |
| MSGS | 20.20% | $5.33B | +30.70% | 0.00% |
| HPQ | 20.19% | $35.53B | +32.29% | 2.99% |
| BHE | 19.82% | $1.70B | +86.81% | 1.41% |
| TEVA | 19.77% | $19.05B | +81.34% | 0.00% |
| PJT | 19.48% | $3.69B | +85.94% | 0.65% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| BNL | -<0.01% | $3.21B | +9.29% | 6.76% |
| CSAN | <0.01% | $3.57B | -47.92% | 4.24% |
| CHH | <0.01% | $6.84B | +27.72% | 0.79% |
| IPG | <0.01% | $10.30B | -8.50% | 4.72% |
| EPAC | <0.01% | $2.55B | +69.58% | 0.09% |
| PATH | 0.01% | $7.02B | -29.77% | 0.00% |
| CLX | 0.01% | $20.81B | +20.66% | 2.88% |
| NAPA | 0.01% | $1.63B | +9.61% | 0.00% |
| HBT | -0.01% | $753.01M | +23.37% | 3.51% |
| EVH | 0.01% | $1.39B | -58.46% | 0.00% |
| HFWA | -0.02% | $873.99M | +47.58% | 3.58% |
| EG | 0.02% | $15.92B | -8.98% | 2.02% |
| BYRN | -0.02% | $479.70M | +295.19% | 0.00% |
| CNK | 0.03% | $4.09B | +138.59% | 0.00% |
| ACRE | 0.03% | $388.89M | -28.20% | 15.31% |
| KHC | -0.04% | $36.98B | -10.45% | 5.23% |
| ACLX | 0.04% | $4.74B | +69.19% | 0.00% |
| STEL | 0.04% | $1.58B | +26.76% | 1.77% |
| ALNT | 0.04% | $419.62M | -4.92% | 0.36% |
| CMTL | -0.05% | $84.44M | -76.16% | 0.00% |
ETF's related to AMED
News
Yahoo
On Tuesday, the U.S. Justice Department said it will block UnitedHealth Group Inc.’s (NYSE:UNH) multi-billion acquisition of Amedisys Inc. (NASDAQ:AMED). The Justice Department has sued to block UnitedHealth’s $3.3 billion purchase of healthcare services company Amedisys, citing concerns about competition in the home health services market. UnitedHealth’s Optum unit launched a website that aims to highlight the benefits of the combination. The website notes that the home healthcare industry rema
Yahoo
The DOJ suggests that UNH's acquisitions reflect a strategy of buying competitors rather than competing directly, potentially giving it control over multiple markets.
Yahoo
The Justice Department on Tuesday sued to block UnitedHealth Group $3.3 billion acquisition of Amedisys alleging the deal would give the health-industry giant too much power over the market for home health and hospice services. The government’s move represents an effort to stem the roll-up of different healthcare services under a single owner. UnitedHealth last year acquired one of Amedisys’s major competitors, LHC Group.
Yahoo
The Justice Department is suing to block UnitedHealth Group's $3.3 billion purchase of Amedisys, citing concerns the combination would hinder access to home health and hospice services in the U.S. The antitrust complaint, filed in Maryland by the Justice Department and four states' attorneys general Tuesday, argues that a potential merger is illegal because the two companies are "such large competitors" already — and the deal would give UnitedHealth too much control in many local markets. “American healthcare is unwell," Assistant Attorney General Jonathan Kanter of the Justice Department’s antitrust division, said in a prepared statement.
Yahoo
A new Department of Justice lawsuit has put at risk UnitedHealth Group effort to buy Amedisys one of the country’s largest providers of home health and hospice care for older people. UnitedHealth itself is already one of the largest providers of home health and hospice care in the U.S. In a suit seeking to block the deal, filed Tuesday in a federal district court in Maryland, the DOJ’s antitrust division argued that the combination would hurt consumers and the nurses who work for the companies. In addition to the DOJ’s antitrust division, the suit was also brought by state attorneys general from Maryland, Illinois, New Jersey, and New York.
Yahoo
Update: DOJ, 4 State Attorneys General Sue to Block UnitedHealth's $3.3 Billion Acquisition of Amedisys
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.